FECC in European Biocides Alliance

FECC in European Biocides Alliance
FECC in European Biocides Alliance

The European Association of Chemical Distributors (FECC) has joined a European cross-industry alliance to ensure faster access to biocides during the ongoing coronavirus pandemic.

At the instigation of the International Association for Soaps, Detergents and Maintenance Products (AISE), FECC and European Chemical Industry Council (CEFIC) sector group the European Biocidal Products Forum are collaborating to provide the industry with quicker access to relevant information so that authorities, medical facilities and the general public all have enough disinfectants to tackle Covid-19.

Consequently, the alliance has issued guidance to assist companies in complying with obligations under Europe’s Biocidal Products Regulation (BPR) and equivalent national biocides laws. The guide was developed with voluntary contributions from the Consultancy for Environmental & Human Toxicology and Risk Assessment (CEHTRA), and law firms Fieldfisher and Steptoe & Johnson.

The bulk of the guide lays out the main procedures for fast-tracking the availability of disinfectants, while two appendices provide an overview of national laws and all the active substances either approved or under review in the EU.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.